These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 9510219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.
    Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM, HGDH Study Group.
    Am J Psychiatry; 2003 Aug; 160(8):1396-404. PubMed ID: 12900300
    [Abstract] [Full Text] [Related]

  • 5. Anxious-depressive symptoms in schizophrenia: a new treatment target for pharmacotherapy?
    Tollefson GD, Sanger TM.
    Schizophr Res; 1999 Mar 01; 35 Suppl():S13-21. PubMed ID: 10190222
    [Abstract] [Full Text] [Related]

  • 6. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.
    Tollefson GD, Sanger TM.
    Am J Psychiatry; 1997 Apr 01; 154(4):466-74. PubMed ID: 9090332
    [Abstract] [Full Text] [Related]

  • 7. Superior efficacy of olanzapine over haloperidol: analysis of patients with schizophrenia from a multicenter international trial.
    Gomez JC, Crawford AM.
    J Clin Psychiatry; 2001 Apr 01; 62 Suppl 2():6-11. PubMed ID: 11232753
    [Abstract] [Full Text] [Related]

  • 8. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP, Khan A, Iskander A, Abad MT, Parker B.
    J Clin Psychiatry; 2007 Mar 01; 68(3):368-79. PubMed ID: 17388705
    [Abstract] [Full Text] [Related]

  • 9. Effective resolution with olanzapine of acute presentation of behavioral agitation and positive psychotic symptoms in schizophrenia.
    Kinon BJ, Roychowdhury SM, Milton DR, Hill AL.
    J Clin Psychiatry; 2001 Mar 01; 62 Suppl 2():17-21. PubMed ID: 11232746
    [Abstract] [Full Text] [Related]

  • 10. Olanzapine: an updated review of its use in the management of schizophrenia.
    Bhana N, Foster RH, Olney R, Plosker GL.
    Drugs; 2001 Mar 01; 61(1):111-61. PubMed ID: 11217867
    [Abstract] [Full Text] [Related]

  • 11. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM, Lieberman JA, Tohen M, Grundy S, Beasley C, Tollefson GD.
    Am J Psychiatry; 1999 Jan 01; 156(1):79-87. PubMed ID: 9892301
    [Abstract] [Full Text] [Related]

  • 12. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
    Ascher-Svanum H, Stensland M, Zhao Z, Kinon BJ.
    BMC Psychiatry; 2005 Jan 13; 5():3. PubMed ID: 15649317
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life?
    Tollefson GD, Andersen SW.
    J Clin Psychiatry; 1999 Jan 13; 60 Suppl 5():23-9; discussion 30. PubMed ID: 10192404
    [Abstract] [Full Text] [Related]

  • 19. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.
    Am J Psychiatry; 2002 Feb 13; 159(2):255-62. PubMed ID: 11823268
    [Abstract] [Full Text] [Related]

  • 20. Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: results of the Japan multicenter, double-blind olanzapine trial.
    Ishigooka J, Inada T, Miura S.
    Psychiatry Clin Neurosci; 2001 Aug 13; 55(4):403-14. PubMed ID: 11442893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.